Korean J Med.  2004 Feb;66(2):214-218.

A case of the overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis

Affiliations
  • 1Department of Internal Medicine, Dong-A University, College of Medicine, Busan, Korea. syhan@hanmail.net
  • 2Department of pathology, Dong-A University, College of Medicine, Busan, Korea.

Abstract

Primary biliary cirrhosis and autoimmune hepatitis are the two main immune-mediated liver diseases. They are generally differentiated easily on the basis of clinical, biochemical, serological, and histological findings. Occasionally, the normally distinctive features overlap and classification of a given patient's chronic liver disease is difficult. Series of such patients with Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome were reported. We report a case of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome proven by clinicopathology. The patient showed hepatitic features including easy fatigability, icteric sclera. Markers of hepatitis B and C virus were absent. The liver biopsy showed chronic hepatitis with piecemeal necrosis, infiltration of inflammatory cell surrounding bile duct. The clinical data of high titers of antinuclear antibodies and antimitochondral antibodies, elevated serum IgM, suggest mixed features of primary biliary cirrhosis-autoimmune hepatitis. The patient as given only ursodeoxycholic acid (600 mg/day), then was observed follow-up regularly.

Keyword

Autoimmune hepatitis; Primary biliary cirrhosis

MeSH Terms

Antibodies
Antibodies, Antinuclear
Bile Ducts
Biopsy
Classification
Follow-Up Studies
Hepatitis
Hepatitis B
Hepatitis, Autoimmune*
Hepatitis, Chronic
Humans
Immunoglobulin M
Liver
Liver Cirrhosis, Biliary*
Liver Diseases
Necrosis
Sclera
Ursodeoxycholic Acid
Antibodies
Antibodies, Antinuclear
Immunoglobulin M
Ursodeoxycholic Acid
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr